Jafron Biomedical Revenue

Jafron Biomedical had revenue of 547.84M CNY in the quarter ending March 31, 2025, a decrease of -26.40%. This brings the company's revenue in the last twelve months to 2.48B, up 18.47% year-over-year. In the year 2024, Jafron Biomedical had annual revenue of 2.68B with 39.27% growth.

Revenue (ttm)

2.48B

Revenue Growth

+18.47%

P/S Ratio

6.87

Revenue / Employee

886.96K

Employees

2,797

Market Cap

17.04B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.68B	754.97M	39.27%
Dec 31, 2023	1.92B	-569.09M	-22.84%
Jan 1, 2023	2.49B	-184.02M	-6.88%
Jan 1, 2022	2.68B	724.67M	37.15%
Dec 31, 2020	1.95B	518.96M	36.24%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	27.98B
Shenzhen Mindray Bio-Medical Electronics	37.11B
WuXi AppTec	37.92B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Aier Eye Hospital Group	20.62B
Sichuan Biokin Pharmaceutical	5.82B
Yunnan Baiyao Group Co.,Ltd	40.03B
Shanghai United Imaging Healthcare	10.30B

Revenue Rankings